Table 3 Significantly differentially expressed miRNAs in MAC-T cells between treatments (challenged with E. coli or S. aureus bacteria) and controls at same time points

6 h

bta-miR-193a-3p

0.37

-1.416

4.30E-06

bta-miR-2339

4.56

2.188

0.0427

bta-miR-365-3p

1.52

0.608

4.47E-03

bta-miR-184

1.27

0.343

0.019

bta-miR-24-3p

1.33

0.411

0.0229

bta-miR-30c

0.75

-0.406

0.024

bta-miR-30b-5p

0.71

-0.502

0.048

12 h

bta-miR-21-3p

1.85

0.886

1.27E-03

bta-miR-21-3p

1.79

0.836

4.20E-03

bta-miR-148a

1.43

0.516

0.0200

bta-miR-423-5p

0.67

-0.578

0.0168

bta-miR-423-5p

0.69

-0.545

0.0205

bta-miR-499

0.06

-3.998

0.0300

bta-miR-92a

1.37

0.454

0.0389

bta-miR-92a

1.36

0.449

0.0428

24 h

bta-miR-423-5p

1.58

0.658

1.21E-03

bta-miR-193a-3p

0.62

-0.700

7.78E-03

bta-miR-21-3p

1.68

0.751

2.43E-03

bta-miR-23a

1.46

0.550

0.0137

bta-let-7a-5p

0.69

-0.544

3.43E-03

bta-miR-99b

0.69

-0.540

0.0154

bta-miR-184

0.76

-0.394

0.0326

bta-miR-21-3p

1.55

0.636

0.0191

bta-miR-un5

0.52

-0.940

0.0444

bta-miR-un5

0.47

-1.077

0.0238

48 h

bta-miR-486

1.94

0.955

6.46E-04

bta-miR-193a-3p

0.20

-2.302

4.49E-08

bta-miR-193a-3p

0.64

-0.650

0.0183

bta-miR-365-3p

2.49

1.315

6.87E-04

bta-miR-30c

0.55

-0.871

0.0191

bta-miR-30b-5p

0.53

-0.904

0.0241